NCT05323682

Brief Summary

Pediatric epilepsy has been described as an age related-condition, and it has a strong impact on childhood quality of life. Psychological symptoms and self-esteem impairment are common facts. Although there are some studies studying the benefits of physical exercise in order to improve seizure control in adults with epilepsy, we have not found studies that support it in pediatric population. Few studieshave reported in childhood some benefits in terms of quality of life, self-esteem and improvement of neuropsychological symptoms. Therefore, it is necessary to use a validated and applicable scale of quality of life in children with epilepsy. Otherwise, findings may be difficult to reproduce

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
Last Updated

April 19, 2022

Status Verified

April 1, 2022

Enrollment Period

1 year

First QC Date

April 1, 2022

Last Update Submit

April 12, 2022

Conditions

Outcome Measures

Primary Outcomes (10)

  • PedsQL (Pediatric Quality of Life Inventory)

    Likert scale 0-5

    Up to 6 months

  • (Quality of Life in Childhood Epilepsy Questionary, QoLCE)

    16 items version

    Up to 6 months

  • PAQ-C (Physical Activity Questionnaire)

    Likert scale 0-5

    Up to 6 months

  • BMI (Body mass index)

    (kg)/height (m2)

    Up to 6 months

  • Waist/hip ratio

    ICC= w/h (cm)

    Up to 6 months

  • Tricipital skinfold

    Thickness of the skinfold located over the triceps muscle

    Up to 6 months

  • Subscapular skinfold

    Thickness of localized adipose tissue immediately below the inferior angle of the scapula

    Up to 6 months

  • Lower extremity strength

    Standing Long Jump Test

    Up to 6 months

  • Grip strength

    Takei Tkk 5401 Digital Hand Dynamometer below the inferior angle of the scapula

    Up to 6 months

  • Cardiorespiratory fitness.

    It was carried out with the Course Navette test (round trip 20 meters)

    Up to 6 months

Study Arms (2)

Experimental

EXPERIMENTAL

Individualized physical exercise program

Other: Individualized physical exercise program

Control

ACTIVE COMPARATOR

No individualized physical exercise program

Other: NO Individualized physical exercise program

Interventions

An individualized physical exercise program was programmed, monitored remotely by e-mail or the use of an activity wristband

Experimental

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 5-14 years
  • Diagnosis of epilepsy (must meet at least one of the following criteria):
  • At least 2 unprovoked seizures in a period of more than 24 hours
  • A seizure and probability of future seizures similar to the general risk of recurrence (60% or more) than if the patient had had 2 crises.
  • Diagnosis of epileptic syndrome.
  • Adequate communication skills with your family.
  • Absence of significant motor limitation.
  • Parents or legal guardians must have given consent to participate in the study.

You may not qualify if:

  • Failure to meet any of the aforementioned requirements.
  • Failure to complete completely and/or legibly any of the instruments of evaluation. c) Abandonment criteria
  • \. Failure to deliver the submitted questionnaires in a timely manner. 2. Failure to attend the scheduled appointment to complete the questionnaires control. 3. Not responding to phone calls, e-mails or requests made to make a new appointment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, 30120, Spain

RECRUITING

Central Study Contacts

Salvador Ibañez-Mico, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, experimental, randomized
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2022

First Posted

April 12, 2022

Study Start

January 1, 2020

Primary Completion

January 1, 2021

Study Completion

August 30, 2022

Last Updated

April 19, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations